Phage therapy pharmacology: calculating phage dosing
1Department of Microbiology, The Ohio State University, Mansfield, OH, USA.
Advances in Applied Microbiology
|November 5, 2011
Summary
Phage therapy uses bacteriophages (phages) to control bacteria. This study presents calculations for phage dosing, crucial for developing effective phage therapy and biocontrol products.
Area of Science:
- Microbiology
- Virology
- Biotechnology
Background:
- Phage therapy, using bacteriophages (phages) to control bacteria, is a promising alternative to antibiotics.
- Rational development of phage therapy requires predictive dosing calculations.
- Current understanding of phage dosing parameters needs consolidation and accessible formulation.
Purpose of the Study:
- To provide a theoretical basis for phage therapy dosing calculations.
- To consolidate and present key concepts relevant to phage dosing in one location.
- To facilitate the rational development of phage therapy and biocontrol products.
Main Methods:
- Theoretical analysis of phage therapy dosing concepts.
- Derivation and presentation of formulae for key parameters.
- Discussion of the relative importance of various dosing factors.
Main Results:
- Exploration of concepts including minimum inhibitory concentration, minimum bactericidal concentration, decimal reduction time, and bacterial eradication time.
- Introduction of thresholds for phage population growth (proliferation threshold) and half-maximal growth rates (K(B)).
- Analysis of phage killing titers, multiplicity of infection, and peak phage densities.
Conclusions:
- Phage density is a critical factor in the efficacy of phage therapy for bacterial eradication.
- The presented calculations offer a framework for optimizing phage therapy dosing.
- Accessible formulae and derivations aid in the implementation and comparison of phage therapy strategies.
Related Concept Videos
Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
DNA Bacteriophages
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
Lysogenic Cycle of Bacteriophages
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Viral Replication: Lytic Cycle
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...


